MM
Madhav Mukund Agarwal
About Madhav Mukund Agarwal
Data last updated:
Madhav Mukund Agarwal is a Director at Vego & Thomson India Private Limited (since 2019), Director at Br Biomedical Private Limited (since 2018) and Director at Vego & Thomson Infra-Tech (India) Private Limited (since 2022), and holds 2 more current directorships. The companies operate in Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹44.32 Cr; the largest is Vego & Thomson India Private Limited at ₹24.53 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Nov 2019 | 2019 | ₹24.53 Cr (FY 2025) | Active | |
| Director | 11 Dec 2018 | 2006 | ₹19.60 Cr (FY 2025) | Active | |
| Director | 26 May 2022 | 2022 | ₹19.4 Lakh (FY 2025) | Active | |
| Designated Partner | 31 Jan 2025 | 2025 | Active | ||
| Designated Partner | 31 Jan 2025 | 2025 | Active |
Board colleagues of Madhav Mukund Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nitasha Agarwal | 01873899 | Vego & Thomson India Private Limited , Br Biomedical Private Limited and 3 more | Director |
| Chanchal Sharma | Br Biomedical Private Limited | Company Secretary | |
| Dipika Singh | Br Biomedical Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Madhav Mukund Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Madhav Mukund Agarwal
Madhav Mukund Agarwal currently holds 5 directorships: Vego & Thomson India Private Limited (Director, since 18 Nov 2019, revenue ₹24.53 Cr (FY 2025)); Br Biomedical Private Limited (Director, since 11 Dec 2018, revenue ₹19.60 Cr (FY 2025)); Vego & Thomson Infra-Tech (India) Private Limited (Director, since 26 May 2022, revenue ₹19.4 Lakh (FY 2025)); Mma Tradex Llp (Designated Partner, since 31 Jan 2025); Divyaputri Tradex Llp (Designated Partner, since 31 Jan 2025).
Madhav Mukund Agarwal was first appointed on 11 Dec 2018 as Director at Br Biomedical Private Limited. The most recent appointment on record is 31 Jan 2025 at Divyaputri Tradex Llp.
The 3 current companies of Madhav Mukund Agarwal that report revenue have a combined latest revenue of ₹44.32 Cr: Vego & Thomson India Private Limited ₹24.53 Cr (FY 2025); Br Biomedical Private Limited ₹19.60 Cr (FY 2025); Vego & Thomson Infra-Tech (India) Private Limited ₹19.4 Lakh (FY 2025).
The current boards of Madhav Mukund Agarwal's companies include Nitasha Agarwal (Vego & Thomson India Private Limited), Chanchal Sharma (Br Biomedical Private Limited), Dipika Singh (Br Biomedical Private Limited).